Literature DB >> 2567399

Nebulised budesonide in severe childhood asthma.

J C de Jongste, E J Duiverman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567399     DOI: 10.1016/s0140-6736(89)92831-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Management of asthma in pre-school children.

Authors:  T P McCarthy; W Lenney
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

Review 2.  Nebuliser therapy in childhood.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  Budesonide inhalation suspension for the treatment of asthma in infants and children.

Authors:  William E Berger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

Authors:  K M Hvizdos; B Jarvis
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

5.  Use of budesonide in severe asthmatics aged 1-3 years.

Authors:  G J Connett; C Warde; E Wooler; W Lenney
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

6.  Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension.

Authors:  P Ilangovan; S Pedersen; S Godfrey; K Nikander; N Noviski; J O Warner
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

7.  Acoustically enhanced microfluidic mixer to synthesize highly uniform nanodrugs without the addition of stabilizers.

Authors:  Nguyen Hoai An Le; Hoang Van Phan; Jiaqi Yu; Hak-Kim Chan; Adrian Neild; Tuncay Alan
Journal:  Int J Nanomedicine       Date:  2018-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.